Cargando…
Structural insights into the subtype-selective antagonist binding to the M2 muscarinic receptor
Human muscarinic receptor, M(2) is one of the five subtypes of muscarinic receptors belonging to the family of G protein-coupled receptors. Muscarinic receptors are targets for multiple neurodegenerative diseases. The challenge has been designing subtype selective ligands against one of the five mus...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462224/ https://www.ncbi.nlm.nih.gov/pubmed/30420692 http://dx.doi.org/10.1038/s41589-018-0152-y |
_version_ | 1783410586513571840 |
---|---|
author | Suno, Ryoji Lee, Sangbae Maeda, Shoji Yasuda, Satoshi Yamashita, Keitaro Hirata, Kunio Horita, Shoichiro Tawaramoto, Maki S. Tsujimoto, Hirokazu Murata, Takeshi Kinoshita, Masahiro Vaidehi, Nagarajan Yamamoto, Masaki Kobilka, Brian K Vaidehi, Nagarajan Iwata, So Kobayashi, Takuya |
author_facet | Suno, Ryoji Lee, Sangbae Maeda, Shoji Yasuda, Satoshi Yamashita, Keitaro Hirata, Kunio Horita, Shoichiro Tawaramoto, Maki S. Tsujimoto, Hirokazu Murata, Takeshi Kinoshita, Masahiro Vaidehi, Nagarajan Yamamoto, Masaki Kobilka, Brian K Vaidehi, Nagarajan Iwata, So Kobayashi, Takuya |
author_sort | Suno, Ryoji |
collection | PubMed |
description | Human muscarinic receptor, M(2) is one of the five subtypes of muscarinic receptors belonging to the family of G protein-coupled receptors. Muscarinic receptors are targets for multiple neurodegenerative diseases. The challenge has been designing subtype selective ligands against one of the five muscarinic receptors. We report high resolution structures of a thermostabilized mutant M(2) receptor bound to a subtype selective antagonist AF-DX 384 and a non-selective antagonist NMS. The thermostabilizing mutation S110R in M(2) was predicted using a theoretical strategy previously developed in our group. Comparison of the crystal structures and pharmacological properties of the M(2) receptor shows that the Arg in the S110R mutant mimics the stabilizing role of the sodium cation, that is known to allosterically stabilize inactive state(s) of class A GPCRs. Molecular Dynamics simulations reveal that tightening of the ligand-residue contacts in M(2) receptor compared to M(3) receptor leads to subtype selectivity of AF-DX 384. |
format | Online Article Text |
id | pubmed-6462224 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
record_format | MEDLINE/PubMed |
spelling | pubmed-64622242019-05-12 Structural insights into the subtype-selective antagonist binding to the M2 muscarinic receptor Suno, Ryoji Lee, Sangbae Maeda, Shoji Yasuda, Satoshi Yamashita, Keitaro Hirata, Kunio Horita, Shoichiro Tawaramoto, Maki S. Tsujimoto, Hirokazu Murata, Takeshi Kinoshita, Masahiro Vaidehi, Nagarajan Yamamoto, Masaki Kobilka, Brian K Vaidehi, Nagarajan Iwata, So Kobayashi, Takuya Nat Chem Biol Article Human muscarinic receptor, M(2) is one of the five subtypes of muscarinic receptors belonging to the family of G protein-coupled receptors. Muscarinic receptors are targets for multiple neurodegenerative diseases. The challenge has been designing subtype selective ligands against one of the five muscarinic receptors. We report high resolution structures of a thermostabilized mutant M(2) receptor bound to a subtype selective antagonist AF-DX 384 and a non-selective antagonist NMS. The thermostabilizing mutation S110R in M(2) was predicted using a theoretical strategy previously developed in our group. Comparison of the crystal structures and pharmacological properties of the M(2) receptor shows that the Arg in the S110R mutant mimics the stabilizing role of the sodium cation, that is known to allosterically stabilize inactive state(s) of class A GPCRs. Molecular Dynamics simulations reveal that tightening of the ligand-residue contacts in M(2) receptor compared to M(3) receptor leads to subtype selectivity of AF-DX 384. 2018-11-12 2018-12 /pmc/articles/PMC6462224/ /pubmed/30420692 http://dx.doi.org/10.1038/s41589-018-0152-y Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Suno, Ryoji Lee, Sangbae Maeda, Shoji Yasuda, Satoshi Yamashita, Keitaro Hirata, Kunio Horita, Shoichiro Tawaramoto, Maki S. Tsujimoto, Hirokazu Murata, Takeshi Kinoshita, Masahiro Vaidehi, Nagarajan Yamamoto, Masaki Kobilka, Brian K Vaidehi, Nagarajan Iwata, So Kobayashi, Takuya Structural insights into the subtype-selective antagonist binding to the M2 muscarinic receptor |
title | Structural insights into the subtype-selective antagonist binding to the M2 muscarinic receptor |
title_full | Structural insights into the subtype-selective antagonist binding to the M2 muscarinic receptor |
title_fullStr | Structural insights into the subtype-selective antagonist binding to the M2 muscarinic receptor |
title_full_unstemmed | Structural insights into the subtype-selective antagonist binding to the M2 muscarinic receptor |
title_short | Structural insights into the subtype-selective antagonist binding to the M2 muscarinic receptor |
title_sort | structural insights into the subtype-selective antagonist binding to the m2 muscarinic receptor |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462224/ https://www.ncbi.nlm.nih.gov/pubmed/30420692 http://dx.doi.org/10.1038/s41589-018-0152-y |
work_keys_str_mv | AT sunoryoji structuralinsightsintothesubtypeselectiveantagonistbindingtothem2muscarinicreceptor AT leesangbae structuralinsightsintothesubtypeselectiveantagonistbindingtothem2muscarinicreceptor AT maedashoji structuralinsightsintothesubtypeselectiveantagonistbindingtothem2muscarinicreceptor AT yasudasatoshi structuralinsightsintothesubtypeselectiveantagonistbindingtothem2muscarinicreceptor AT yamashitakeitaro structuralinsightsintothesubtypeselectiveantagonistbindingtothem2muscarinicreceptor AT hiratakunio structuralinsightsintothesubtypeselectiveantagonistbindingtothem2muscarinicreceptor AT horitashoichiro structuralinsightsintothesubtypeselectiveantagonistbindingtothem2muscarinicreceptor AT tawaramotomakis structuralinsightsintothesubtypeselectiveantagonistbindingtothem2muscarinicreceptor AT tsujimotohirokazu structuralinsightsintothesubtypeselectiveantagonistbindingtothem2muscarinicreceptor AT muratatakeshi structuralinsightsintothesubtypeselectiveantagonistbindingtothem2muscarinicreceptor AT kinoshitamasahiro structuralinsightsintothesubtypeselectiveantagonistbindingtothem2muscarinicreceptor AT vaidehinagarajan structuralinsightsintothesubtypeselectiveantagonistbindingtothem2muscarinicreceptor AT yamamotomasaki structuralinsightsintothesubtypeselectiveantagonistbindingtothem2muscarinicreceptor AT kobilkabriank structuralinsightsintothesubtypeselectiveantagonistbindingtothem2muscarinicreceptor AT vaidehinagarajan structuralinsightsintothesubtypeselectiveantagonistbindingtothem2muscarinicreceptor AT iwataso structuralinsightsintothesubtypeselectiveantagonistbindingtothem2muscarinicreceptor AT kobayashitakuya structuralinsightsintothesubtypeselectiveantagonistbindingtothem2muscarinicreceptor |